Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a pharmaceutical company dedicated to making drugs affordable again through its Branded Compounding™ business model, today announced the availability of its new MaxRx Prescriber Portal™, a software application that provides physicians with new order entry and management tools that have traditionally not been available for compounded prescriptions. In addition to allowing a streamlined ordering process for single and multiple orders, MaxRx has numerous other functions designed to give the prescriber maximum visibility into order workflow, and maximum flexibility in communicating and doing business with an ImprimisRx pharmacy.
Dr. Paul Anderson, CEO of Anderson Medical Group in Seattle, Washington, stated, "We run an extremely busy multi practitioner multi location practice and having this ability to quickly and accurately order from Imprimis is now an essential part of the efficient operation of our business. Once we started using the MaxRx portal, we would not go back to the old way of doing things."
Mark L. Baum, CEO of Imprimis, stated, "Imprimis is taking the lead by offering the latest advancements in prescription management information technology to better serve our customers, improve patient care and safety and meet federal and state compliance requirements. MaxRx was uniquely developed over the past year in order to provide new conveniences for our customers and a simple and transparent compound prescription ordering and management process. Our goal is to provide the best in class customer service and the MaxRx Prescriber Portal is an important step in caring for our growing base of valued customers. We intend to continue to develop and integrate new processes and systems, like the MaxRx Prescriber Portal, in order to scale our business and expand our reach as we move into the next phase of our growth and maturity."
From gut to mind: Exploring prebiotics and probiotics as dual fighters against depression and obesity